BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35504682)

  • 1. Ovarian fibromatosis: "The black garland sign".
    Santos Urios M; García Espasa C; Concepción Aramendía L
    Radiologia (Engl Ed); 2022; 64(2):164-168. PubMed ID: 35504682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian Fibromatosis: "The black garland sign".
    Urios MS; García Espasa C; Concepción Aramendía L
    Radiologia (Engl Ed); 2021 Feb; ():. PubMed ID: 33551120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The black garland sign in ovarian fibromatosis.
    Diaz A; Yarmish G; Hayim M
    Abdom Radiol (NY); 2018 Jul; 43(7):1785-1786. PubMed ID: 29143075
    [No Abstract]   [Full Text] [Related]  

  • 4. Ovarian fibromatosis: The "black garland" sign.
    Montoriol PF; Bayol B
    Diagn Interv Imaging; 2020 Apr; 101(4):259-260. PubMed ID: 31711935
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian fibromatosis associated with large pedunculated fibroma in a 30-year-old woman: A rare coincidence or variant?
    Takeda A; Watanabe K; Koike W
    J Obstet Gynaecol Res; 2024 Feb; 50(2):270-274. PubMed ID: 37968569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian fibromatosis: magnetic resonance imaging findings with pathologic correlation.
    Takeuchi M; Matsuzaki K; Sano N; Furumoto H; Nishitani H
    J Comput Assist Tomogr; 2008; 32(5):776-7. PubMed ID: 18830110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T2-weighted imaging hypointensity in an ovarian lesion: is it a benign finding?
    Alcala JMF; Mussi TC; Raiza LCP; Baroni RH
    Einstein (Sao Paulo); 2022; 20():eAO6851. PubMed ID: 35649059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrioid adenocarcinoma of the ovary: MRI findings with emphasis on diffusion-weighted imaging for the differentiation of ovarian tumors.
    Kovač JD; Terzić M; Mirković M; Banko B; Đikić-Rom A; Maksimović R
    Acta Radiol; 2016 Jun; 57(6):758-66. PubMed ID: 26307063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI combined with clinical features to differentiate ovarian thecoma-fibroma with cystic degeneration from ovary adenofibroma.
    Bo J; Sun M; Wei C; Wei L; Fu B; Shi B; Fang X; Dong J
    Br J Radiol; 2024 May; 97(1157):1057-1065. PubMed ID: 38402483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian fibromas and fibrothecomas: sonographic correlation with computed tomography and magnetic resonance imaging: a 5-year single-institution experience.
    Yen P; Khong K; Lamba R; Corwin MT; Gerscovich EO
    J Ultrasound Med; 2013 Jan; 32(1):13-8. PubMed ID: 23269706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of MRI in the differential diagnosis between benign and malignant ovarian tumors.
    Zhang T; Yi X; Lu J; Fu A
    Eur J Gynaecol Oncol; 2017; 38(2):257-262. PubMed ID: 29953791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI features of ovarian cystic lesions.
    Park SB; Lee JB
    J Magn Reson Imaging; 2014 Sep; 40(3):503-15. PubMed ID: 24474469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrous tumours of the ovary: aetiologies and MRI features.
    Montoriol PF; Mons A; Da Ines D; Bourdel N; Tixier L; Garcier JM
    Clin Radiol; 2013 Dec; 68(12):1276-83. PubMed ID: 23937826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
    Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
    Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of dynamic contrast-enhanced magnetic resonance imaging in characterizing ovarian tumors classified as indeterminate at ultrasonography.
    Amado Cabana S; Gallego Ojea JC; Félez Carballada M
    Radiologia (Engl Ed); 2022; 64(2):110-118. PubMed ID: 35504676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian fibromas and cystadenofibromas: MRI features of the fibrous component.
    Outwater EK; Siegelman ES; Talerman A; Dunton C
    J Magn Reson Imaging; 1997; 7(3):465-71. PubMed ID: 9170028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging features of ovarian fibroma, fibrothecoma, and thecoma.
    Chung BM; Park SB; Lee JB; Park HJ; Kim YS; Oh YJ
    Abdom Imaging; 2015 Jun; 40(5):1263-72. PubMed ID: 25273949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in magnetic resonance imaging of malignant and borderline tumors associated with ovarian endometriotic cyst comparing with endometriotic cysts without arising malignancy.
    Nishio N; Kido A; Kataoka M; Kuwahara R; Nakao K; Kurata Y; Matsumura N; Mandai M; Togashi K
    Eur J Radiol; 2018 Aug; 105():175-181. PubMed ID: 30017276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging in the differentiation of endometriomas from hemorrhagic cysts in the ovary.
    Lee NK; Kim S; Kim KH; Suh DS; Kim TU; Han GJ; Lee JW; Kim JY
    Acta Radiol; 2016 Aug; 57(8):998-1005. PubMed ID: 26543051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian cystadenofibromas: characteristic magnetic resonance findings with pathologic correlation.
    Takeuchi M; Matsuzaki K; Kusaka M; Shimazu H; Yoshida S; Nishitani H; Uehara H
    J Comput Assist Tomogr; 2003; 27(6):871-3. PubMed ID: 14600453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.